Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts


  Free Subscription


2 Acta Psychiatr Scand
1 Am J Med Genet B Neuropsychiatr Genet
1 Am J Psychiatry
3 Biol Psychiatry
2 Br J Psychiatry
2 J Clin Psychopharmacol
1 Mol Psychiatry
1 Neuropsychopharmacology
2 PLoS One
4 Psychiatry Res
2 Psychol Med
2 Schizophr Res

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Acta Psychiatr Scand

  1. GALLING B, Vernon JA, Pagsberg AK, Wadhwa A, et al
    Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia.
    Acta Psychiatr Scand. 2018;137:187-205.
    PubMed     Text format     Abstract available

  2. MA CH, Chang SS, Tsai HJ, Gau SS, et al
    Comparative effect of antipsychotics on risk of self-harm among patients with schizophrenia.
    Acta Psychiatr Scand. 2018 Feb 11. doi: 10.1111/acps.12857.
    PubMed     Text format     Abstract available

    Am J Med Genet B Neuropsychiatr Genet

  3. SAKAMOTO K, Crowley JJ
    A comprehensive review of the genetic and biological evidence supports a role for MicroRNA-137 in the etiology of schizophrenia.
    Am J Med Genet B Neuropsychiatr Genet. 2018;177:242-256.
    PubMed     Text format     Abstract available

    Am J Psychiatry

  4. RAHMAN T, Ash DM, Lauriello J, Rawlani R, et al
    Misleading Guidance From Pharmacogenomic Testing.
    Am J Psychiatry. 2017;174:922-924.
    PubMed     Text format    

    Biol Psychiatry

    Excitatory Amino Acids in Schizophrenia: Both What You Have, and What You Do With Them.
    Biol Psychiatry. 2018;83:470-472.
    PubMed     Text format    

  6. RAMSAY IS, MacDonald AW 3rd
    The Ups and Downs of Thalamocortical Connectivity in Schizophrenia.
    Biol Psychiatry. 2018;83:473-474.
    PubMed     Text format    

    Translating Schizophrenia Population Genetics Findings to Neurobiological Mechanisms: The Case of KALRN-9.
    Biol Psychiatry. 2018;83:e41-e42.
    PubMed     Text format    

    Br J Psychiatry

  8. VAN DEN BERG D, de Bont PAJM, van der Vleugel BM, de Roos C, et al
    Long-term outcomes of trauma-focused treatment in psychosis.
    Br J Psychiatry. 2018 Feb 7:1-3. doi: 10.1192/bjp.2017.
    PubMed     Text format     Abstract available

  9. BRESSAN RA, Grohs GEM, Matos G, Shergill S, et al
    Hope or hype in the treatment of schizophrenia - what's the role of the physician?
    Br J Psychiatry. 2018;212:1-3.
    PubMed     Text format     Abstract available

    J Clin Psychopharmacol

  10. HAJI SEYED JAVADI A, Shafikhani AA, Zamir SM, Khanshir ZF, et al
    Evaluation of the Effect of Fluvoxamine in Patients With Schizophrenia Under Risperidone Treatment: A Clinical Trial.
    J Clin Psychopharmacol. 2018 Feb 9. doi: 10.1097/JCP.0000000000000850.
    PubMed     Text format     Abstract available

  11. LIU F, Xie L, Zhang B, Ruan Y, et al
    No Effect of Adjunctive Minocycline Treatment on Body Metabolism in Patients With Schizophrenia.
    J Clin Psychopharmacol. 2018 Feb 8. doi: 10.1097/JCP.0000000000000841.
    PubMed     Text format     Abstract available

    Mol Psychiatry

  12. KIM DD, Barr AM, Honer WG, Procyshyn RM, et al
    Exercise-induced hippocampal neurogenesis: 5-HT3 receptor antagonism by antipsychotics as a potential limiting factor in Schizophrenia.
    Mol Psychiatry. 2018 Feb 8. pii: 10.1038/s41380-018-0022.
    PubMed     Text format    


  13. MODINOS G, Simsek F, Azis M, Bossong M, et al
    Prefrontal GABA levels, hippocampal resting perfusion and the risk of psychosis.
    Neuropsychopharmacology. 2018 Jan 30. pii: 10.1038/s41386-017-0004.
    PubMed     Text format     Abstract available

    PLoS One

  14. GONZALEZ DE ARTAZA M, Catalan A, Angosto V, Valverde C, et al
    Can an experimental white noise task assess psychosis vulnerability in adult healthy controls?
    PLoS One. 2018;13:e0192373.
    PubMed     Text format     Abstract available

  15. VAESSEN TSJ, de Jong L, Schafer AT, Damen T, et al
    The interaction between cannabis use and the Val158Met polymorphism of the COMT gene in psychosis: A transdiagnostic meta - analysis.
    PLoS One. 2018;13:e0192658.
    PubMed     Text format     Abstract available

    Psychiatry Res

  16. GHAJAR A, Khoaie-Ardakani MR, Shahmoradi Z, Alavi AR, et al
    L-carnosine as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial.
    Psychiatry Res. 2018;262:94-101.
    PubMed     Text format     Abstract available

  17. SHEN H, Li R, Yan R, Zhou X, et al
    Adjunctive therapy with statins in schizophrenia patients: A meta-analysis and implications.
    Psychiatry Res. 2018;262:84-93.
    PubMed     Text format     Abstract available

  18. MCGREGOR N, Thompson N, O'Connell KS, Emsley R, et al
    Modification of the association between antipsychotic treatment response and childhood adversity by MMP9 gene variants in a first-episode schizophrenia cohort.
    Psychiatry Res. 2018;262:141-148.
    PubMed     Text format     Abstract available

  19. BUSTAN Y, Drapisz A, Ben Dor DH, Avrahami M, et al
    Elevated neutrophil to lymphocyte ratio in non-affective psychotic adolescent inpatients: Evidence for early association between inflammation and psychosis.
    Psychiatry Res. 2018;262:149-153.
    PubMed     Text format     Abstract available

    Psychol Med

  20. VANES LD, Mouchlianitis E, Collier T, Averbeck BB, et al
    Differential neural reward mechanisms in treatment-responsive and treatment-resistant schizophrenia.
    Psychol Med. 2018 Feb 14:1-10. doi: 10.1017/S0033291718000041.
    PubMed     Text format     Abstract available

  21. FERRI J, Ford JM, Roach BJ, Turner JA, et al
    Resting-state thalamic dysconnectivity in schizophrenia and relationships with symptoms.
    Psychol Med. 2018 Feb 15:1-8. doi: 10.1017/S003329171800003.
    PubMed     Text format     Abstract available

    Schizophr Res

  22. MORALES-MUNOZ I, Suvisaari J, Therman S, Torniainen-Holm M, et al
    Childhood adversities and cognitive deficits in first-episode psychosis.
    Schizophr Res. 2018 Feb 7. pii: S0920-9964(18)30050.
    PubMed     Text format    

  23. KUKLA M, Bell MD, Lysaker PH
    A randomized controlled trial examining a cognitive behavioral therapy intervention enhanced with cognitive remediation to improve work and neurocognition outcomes among persons with schizophrenia spectrum disorders.
    Schizophr Res. 2018 Feb 5. pii: S0920-9964(18)30032.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.